小林制藥公司的歷史可以追溯到1886年，當時是一家名為「小林盛大堂」的小型制藥店。隨著時間的推移，公司逐漸擴大業務，成為一家知名的制藥和保健品製造商。公司的核心價值之一是將傳統的製藥知識與現代科學技術相結合，不斷創新以滿足客戶的需求。該公司的主要產品包括：

保健食品：生產各種保健食品，包括維生素、礦物質、膠原蛋白等，以幫助人們維持健康的生活方式。

外用藥品：涵蓋各種不同的需求，包括皮膚護理、疼痛緩解、肌肉舒緩等。

口腔護理產品：如漱口水、牙膏等，幫助保持口腔健康。

貼布和敷料產品：被廣泛應用於緩解疼痛、減輕肌肉疲勞等。

小林制藥一直致力於產品的創新和品質，不斷進行研究和開發，以提供更安全、更有效的產品。透過嚴格控制產品的製造過程，來確保符合最高的標準和規範。儘管小林制藥在日本以及全球范圍內享有良好的聲譽，但最近它也受到一些負面消息的影響。近期有報導指出，該公司的3款保健產品含有紅麴成分，可能導致腎臟疾病。據外媒報導已有26人因使用該產品而住院，其中1人因腎臟疾病死亡。該公司內部正在調查消費者死亡是否與產品有直接關係，並呼籲民眾暫停使用相關產品。目前已回收含有相關成分的3款產品，總數量高達30萬份。此消息一出，立即導致小林制藥的股價暴跌17%。儘管遭遇這些負面消息，小林制藥仍然以其高質量的產品和良好的信譽在行業中佔有一席之地。

The history of Kobayashi Pharmaceutical Co., Ltd. can be traced back to 1886 when it was originally a small pharmacy called "Kobayashi Seidaido." Over time, the company expanded its business and became a well-known manufacturer of pharmaceuticals and health products. One of the core values of the company is to combine traditional pharmaceutical knowledge with modern scientific technology, continuously innovating to meet the needs of customers. The company's main products include:

1. Health supplements: Producing a variety of health supplements including vitamins, minerals, collagen, etc., to help people maintain a healthy lifestyle.

2. External medicines: Covering various needs such as skincare, pain relief, muscle relaxation, etc.

3. Oral care products: Such as mouthwash, toothpaste, etc., to help maintain oral health.

4. Patch and dressing products: Widely used to relieve pain, alleviate muscle fatigue, etc.

Kobayashi Pharmaceutical has always been committed to product innovation and quality, continuously conducting research and development to provide safer and more effective products. Through strict control of the manufacturing process, the company ensures compliance with the highest standards and regulations.

Despite enjoying a good reputation in Japan and globally, Kobayashi Pharmaceutical has recently been affected by some negative news. Reports have indicated that three of the company's health products contain red yeast rice components, which may lead to kidney disease. According to foreign media reports, 26 people have been hospitalized and one person has died from kidney disease after using these products. The company is internally investigating whether consumer deaths are directly related to the products and has urged the public to temporarily suspend the use of related products. Three products containing the relevant components have been recalled, with a total quantity of up to 300,000 units. This news immediately caused Kobayashi Pharmaceutical's stock price to plummet by 17%. Despite facing these negative developments, Kobayashi Pharmaceutical continues to hold a prominent position in the industry with its high-quality products and good reputation.

照片:DALLE3